|
Daily Medical Update
Temporomandibular disorder
Tuesday, June 02, 2026
|
🔬 Practice-Changing Findings
Evidence from RCTs and meta-analyses published in the
last 12 months.
|
Oral diseases (2025) - Meta-Analysis
Key Findings
- i-PRF alone or combined with arthrocentesis or arthroscopy produced significant pain reduction at 3-6 and 8-12 months.
- i-PRF plus arthrocentesis improved maximum mouth opening more than arthrocentesis alone at both 3-6 and 8-12 months.
📋 Practice Implication: For painful articular TMD that has not responded to conservative care, referral for i-PRF-based minimally invasive treatment is supported by medium-term pain and function gains.
|
Dental and medical problems (2025) - Meta-Analysis
Key Findings
- Hyaluronic acid injections reduced pain and improved maximum mouth opening in patients with TMJ pain and dysfunction.
- In the included comparison, hyaluronic acid improved long-term pain and jaw function more than platelet-rich plasma while remaining safe across randomized trials.
📋 Practice Implication: Hyaluronic acid remains a reasonable specialist option for refractory TMJ pain when the goal is durable symptom relief with a favorable safety profile.
|
Journal of oral rehabilitation (2025) - Meta-Analysis
Key Findings
- Patients with migraine were significantly more likely to have TMD (OR 6.08, 95% CI 4.80-7.68).
- Patients with TMD were also more likely to have migraine (OR 2.64, 95% CI 2.19-3.18), with high-certainty evidence.
📋 Practice Implication: Patients presenting with either migraine or TMD should be screened for the other condition so treatment plans address both pain generators early.
|
BMJ open (2026) - Meta-Analysis
Key Findings
- Pain provoked by movement or palpation increased the odds of a worse pain course, including joint pain with sound (OR 2.10) and muscle pain during movement (OR 2.10).
- Shorter pain duration (OR 0.25) reduced the odds of poor outcomes and greater pain-free mouth opening (OR 0.60) improved prognosis, while higher pain intensity increased odds of poorer function (OR 1.39).
📋 Practice Implication: Initial assessment should capture provoked pain, symptom duration, baseline pain intensity, and pain-free opening to identify patients at higher risk for chronic disability.
|
Clinical oral investigations (2025) - Meta-Analysis
Key Findings
- Across 16 studies with 901 patients, arthrocentesis with or without adjuvants significantly improved pain (MD -5.50) and maximum mouth opening (MD 6.97 mm).
- Over 3-12 months, minimally invasive therapies reduced pain and improved jaw opening, although superiority over conservative care was inconsistent for some comparisons.
📋 Practice Implication: In TMJ osteoarthritis with meaningful pain or restricted opening, failure of conservative management should prompt discussion of arthrocentesis-based options rather than prolonged watchful waiting alone.
|
|
💡
Summary
Recent TMD evidence is dominated by meta-analyses of minimally invasive joint therapies plus studies clarifying comorbidity and prognosis. Intra-articular i-PRF, hyaluronic acid, and arthrocentesis-based strategies consistently reduced pain and improved mouth opening, while migraine comorbidity and pain-provocation features identified patients more likely to have persistent symptoms. Current practice should emphasize earlier screening for overlapping headache disorders and faster referral for refractory pain or functional limitation.
|
|